Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT)

…, MM Lieber, AR Kristal, AK Darke, KB Arnold… - Jama, 2009 - jamanetwork.com
Context Secondary analyses of 2 randomized controlled trials and supportive epidemiologic
and preclinical data indicated the potential of selenium and vitamin E for preventing …

Race/ethnicity, obesity, health related behaviors and the risk of symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial

AR Kristal, KB Arnold, JM Schenk… - The Journal of …, 2007 - auajournals.org
Purpose : We examined risk factors for incident symptomatic benign prostate hyperplasia in
5,667 Prostate Cancer Prevention Trial placebo arm participants who were free of benign …

Dietary patterns, supplement use, and the risk of symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial

AR Kristal, KB Arnold, JM Schenk… - American journal of …, 2008 - academic.oup.com
This study examined dietary risk factors for incident benign prostatic hyperplasia (BPH) in
4,770 Prostate Cancer Prevention Trial (1994–2003) placebo-arm participants who were free …

Diet, supplement use, and prostate cancer risk: results from the prostate cancer prevention trial

AR Kristal, KB Arnold, ML Neuhouser… - American journal of …, 2010 - academic.oup.com
The authors examined nutritional risk factors for prostate cancer among 9,559 participants
in the Prostate Cancer Prevention Trial (United States and Canada, 1994–2003). The …

Difference in association of obesity with prostate cancer risk between US African American and non-Hispanic white men in the Selenium and Vitamin E Cancer …

WE Barrington, JM Schenk, R Etzioni, KB Arnold… - JAMA …, 2015 - jamanetwork.com
Importance African American men have the highest rates of prostate cancer incidence and
mortality in the United States. Understanding underlying reasons for this disparity could …

[HTML][HTML] Randomized trial of text messaging to reduce early discontinuation of adjuvant aromatase inhibitor therapy in women with early-stage breast cancer: SWOG …

…, GC Hillyer, A Moseley, KB Arnold… - Journal of Clinical …, 2020 - ncbi.nlm.nih.gov
PURPOSE Nonadherence to aromatase inhibitors (AIs) for breast cancer is common and
increases the risk of recurrence. Text messaging increases adherence to medications for …

Association of symptomatic benign prostatic hyperplasia and prostate cancer: results from the prostate cancer prevention trial

JM Schenk, AR Kristal, KB Arnold… - American journal of …, 2011 - academic.oup.com
This study examined the association between symptomatic benign prostatic hyperplasia (BPH)
and prostate cancer risk in 5,068 placebo-arm participants enrolled in the Prostate …

Serum steroid and sex hormone-binding globulin concentrations and the risk of incident benign prostatic hyperplasia: results from the prostate cancer prevention trial

…, JM Schenk, YJ Song, KB Arnold… - American journal of …, 2008 - academic.oup.com
The authors conducted a nested case-control study of serum steroid concentrations and risk
of benign prostatic hyperplasia (BPH), using data from the placebo arm of the Prostate …

Surgical versus non-surgical management for patients with malignant bowel obstruction (S1316): a pragmatic comparative effectiveness trial

RS Krouse, GL Anderson, KB Arnold… - The Lancet …, 2023 - thelancet.com
Background Malignant small bowel obstruction has a poor prognosis and is associated with
multiple related symptoms. The optimal treatment approach is often unclear. We aimed to …

Finasteride reduces the risk of incident clinical benign prostatic hyperplasia

JK Parsons, JM Schenk, KB Arnold, K Messer, C Till… - European urology, 2012 - Elsevier
BACKGROUND: Despite the high prevalence of clinical benign prostatic hyperplasia (BPH)
among older men, there remains a notable absence of studies focused on BPH prevention. …